160 Health International (HKSE:02656) Beta: N/A (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02656 160 Health International Ltd HKSE:02656
8 GF Score
Price HK$9.64
! 5 Warning Signs
View Full Analysis

What is 160 Health International Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-19), 160 Health International's Beta is Not available.

160 Health International  (HKSE:02656) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

160 Health International Beta Related Terms

160 Health International Beta Historical Data

* Premium members only.

The historical data trend for 160 Health International's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

160 Health International Beta Chart

160 Health International Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Beta
0.00 0.00 0.00 0.00

160 Health International Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
HKSE:02656
8GF Score
160 Health International Ltd HKSE:02656
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

160 Health International Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

160 Health International Business Description

Address 4078 Dongbin Road, Nanshan Street, 9th, 11th - 12th Floor, Building 2, Yongxin Times Square, Nanshan District, Shenzhen, CHN, 518052
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score

Get the complete analysis for HKSE:02656

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$9.64
Price